Fisher Center for Alzheimer's Research Foundation Announces Significant Advances in Alzheimer’s Research and the Launch of Their Summer Campaign to Fund the Search for New Alzheimer’s Treatments

NEW YORK--(BUSINESS WIRE)--Fisher Center for Alzheimer’s Research Foundation announced today a significant new advance in Alzheimer’s research. In 2008, researchers at the Fisher Center laboratory developed a technology by which they could determine the protein composition of each individual nerve cell type in the brain, called TRAP. They are now using this technology to analyze the differences in protein composition between those nerve cells which die in Alzheimer's disease (vulnerable nerve cells) and those nerve cells which do not die (resistant nerve cells). This knowledge will enable their scientists to take genes from vulnerable cells, inject these genes into resistant cells causing their death, and thereby prove that these genes cause cells to be vulnerable and die in Alzheimer's disease. They are preparing to search for inhibitors of the disease-causing genes that they are currently in the process of identifying. These inhibitors are expected to be highly effective in the treatment of Alzheimer's disease.